Bonner-Weir Susan, Sharma Arun
Section of Islet Transplantation and Cellular Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA 02215, USA.
J Pathol. 2002 Jul;197(4):519-26. doi: 10.1002/path.1158.
beta-cell replacement therapy via islet transplantation has had renewed interest, due to the recent improved success. In order to make such a therapy available to more than a few of the thousands of patients with diabetes, new sources of insulin-producing cells must be readily available. The recent conceptual revolution of the presence of adult pluripotent stem cells in bone marrow and in most, if not all, organs suggests that adult stem cells may be a potential source of insulin-producing cells. Pancreatic stem/progenitor cells or markers for these cells have been sought in both islets and ducts. There is considerable evidence that such cells exist and several candidate cells have been reported. However, no clearly identifiable adult pancreatic stem cell has been found as yet. The putative pancreatic stem cells will be the focus of this review.
由于近期成功率的提高,通过胰岛移植进行的β细胞替代疗法重新引起了人们的关注。为了使这种疗法能够应用于成千上万糖尿病患者中的更多人,必须有现成的胰岛素产生细胞新来源。最近关于骨髓以及大多数(如果不是全部)器官中存在成体多能干细胞的概念性革命表明,成体干细胞可能是胰岛素产生细胞的潜在来源。人们在胰岛和导管中都寻找过胰腺干细胞/祖细胞或这些细胞的标志物。有大量证据表明这些细胞存在,并且已经报道了几种候选细胞。然而,迄今为止尚未发现明确可识别的成年胰腺干细胞。本文将聚焦于假定的胰腺干细胞。